Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
CFD
U.S. stock CFD derivatives
US Stocks
Access real US stocks and ETFs
HK Stocks
Trade quality Hong Kong-listed stocks
Stock Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
GUSD
Mint GUSD for Treasury RWA yields
Stocks Activities
Trade Popular Stocks and Unlock Generous Airdrops
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
IPO Access
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Stock Market Wednesday: Defense Stocks and Biotech See Notable Weakness
The aerospace and defense sector faced headwinds during Wednesday trading, with shares sliding about 2.3% as a group. Defense stocks tracked lower on weakness from several key names, including Sidus Space, down roughly 8.4%, and Textron, off about 8.1% on the session. The broad aerospace and defense sector struggles reflected broader market pressure on specialized industrial equipment and defense-related companies.
Paralleling the weakness in aerospace, the biotechnology sector also stumbled Wednesday, declining approximately 2.7% as a group. Leading the biotech selloff were REGENXBIO, which tumbled around 17%, and Forte Biosciences, falling about 12.9%. The dual weakness in these two sectors suggests investors were rotating away from growth and specialty-focused equities as market sentiment shifted during the trading session.